We are live on ! Find out more
GCTK icon

GlucoTrack
GCTK

6 hedge funds and large institutions have $41.5K invested in GlucoTrack in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $40.1K → $41.5K (+$1.42K)

0.05% more ownership

Funds ownership: 0% → 0.05% (+0.05%)

0% more funds holding

Funds holding: 6 → 6 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AF
Alerus Financial
North Dakota
+$30.1K
2
Morgan Stanley
Morgan Stanley
New York
+$2.44K
3
UBS Group
UBS Group
Switzerland
+$271

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$24.7K
2
TRCT
Tower Research Capital (TRC)
New York
-$5.79K
3
Barclays
Barclays
United Kingdom
-$4.51K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$128
5
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
-$6

GCTK Hedge Fund Activity: Q3 2025 in Review

6 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q3 2025, worth a combined $41.5K — up 3.5% from $40.1K a quarter earlier.

Fund positioning in GCTK was balanced in Q3 2025: 3 funds opened new positions, 3 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Alerus Financial, opening a new position worth an estimated $30.1K. The largest seller was Bank of America, exiting entirely with an estimated $24.7K sold.

  • 6 institutional investors held GlucoTrack (GCTK) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $41.5K of GlucoTrack stock for Q3 2025, up 3.5% quarter-over-quarter.
  • 3 funds opened new GlucoTrack positions in Q3 2025 and 3 closed out, a net change of 0 holders.
  • The largest GlucoTrack buyer in Q3 2025 was Alerus Financial, an estimated $30.1K added.
  • The largest GlucoTrack seller in Q3 2025 was Bank of America, an estimated $24.7K sold.

Based on aggregated 13F filings for Q3 2025.